# N-acetylcysteine and NMDA Antagonist Interactions

> **NCT00611897** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 16 (actual)

## Conditions studied

- Cognitive Dysfunction

## Interventions

- **DRUG:** N-acetylcysteine and ketamine
- **DRUG:** placebo and ketamine

## Key facts

- **NCT ID:** NCT00611897
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611897, "N-acetylcysteine and NMDA Antagonist Interactions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00611897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*